gamma-butyrobetaine has been researched along with Coronary Artery Disease in 2 studies
4-(trimethylammonio)butanoate : An amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strand, E | 1 |
| Rebnord, EW | 1 |
| Flygel, MR | 1 |
| Lysne, V | 1 |
| Svingen, GFT | 1 |
| Tell, GS | 1 |
| Løland, KH | 1 |
| Berge, RK | 2 |
| Svardal, A | 2 |
| Nygård, O | 1 |
| Pedersen, ER | 1 |
| Trøseid, M | 1 |
| Mayerhofer, CCK | 1 |
| Broch, K | 1 |
| Arora, S | 1 |
| Hov, JR | 1 |
| Andreassen, AK | 1 |
| Gude, E | 1 |
| Karason, K | 1 |
| Dellgren, G | 1 |
| Gullestad, L | 1 |
| Aukrust, P | 1 |
| Ueland, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Double Blind Study of the Effects of Homocysteine Lowering Therapy on Mortality and Cardiac Events in Patients Undergoing Coronary Angiography[NCT00354081] | Phase 3 | 3,096 participants (Actual) | Interventional | 1999-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for gamma-butyrobetaine and Coronary Artery Disease
| Article | Year |
|---|---|
Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients With Suspected Stable Angina Pectoris.
Topics: Aged; Angina, Stable; Betaine; Body Mass Index; Carnitine; Chromatography, Liquid; Coronary Artery D | 2018 |
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.
Topics: Acute Disease; Adult; Aged; Betaine; Carnitine; Coronary Artery Disease; Cyclosporine; Everolimus; F | 2019 |